
Rare diseases, such as sickle cell disease and thalassemia, affect up to 30 million people in the United States and at least 300 million across the globe. Congress called on the U.S. Food and Drug Administration (FDA) to sponsor a National Academies study on processes for evaluating the safety and efficacy of drugs for rare diseases or conditions in the United States and the European Union. The resulting report provides recommendations for enhancing and promoting rare disease drug...
Compre este e-book e ganhe mais 1 GRÁTIS!
Língua Inglês ● Formato EPUB ● Páginas 386 ● ISBN 9780309726580 ● Editor Carolyn K. Shore & Carson W. Smith ● Editora National Academies Press ● Publicado 2024 ● Carregável 3 vezes ● Moeda EUR ● ID 10044764 ● Proteção contra cópia Adobe DRM
Requer um leitor de ebook capaz de DRM